Stage IIIA Colorectal Cancer AJCC v8 Recruiting Phase 2 Trials for Panitumumab (DB01269)

IndicationStatusPhase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04117945Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerTreatment